APA (7th ed.) Citation

Zucali, P. A., Lopci, E., Ceresoli, G. L., Giordano, L., Perrino, M., Ciocia, G., . . . Santoro, A. (2017). Prognostic and predictive role of [18F]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy. Cancer Medicine, 6(10), 2287. https://doi.org/10.1002/cam4.1182

Chicago Style (17th ed.) Citation

Zucali, Paolo Andrea, et al. "Prognostic and Predictive Role of [18F]fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Patients with Unresectable Malignant Pleural Mesothelioma (MPM) Treated with Up-front Pemetrexed-based Chemotherapy." Cancer Medicine 6, no. 10 (2017): 2287. https://doi.org/10.1002/cam4.1182.

MLA (9th ed.) Citation

Zucali, Paolo Andrea, et al. "Prognostic and Predictive Role of [18F]fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Patients with Unresectable Malignant Pleural Mesothelioma (MPM) Treated with Up-front Pemetrexed-based Chemotherapy." Cancer Medicine, vol. 6, no. 10, 2017, p. 2287, https://doi.org/10.1002/cam4.1182.